Older renal cancer patients appear to benefit from sorafenib treatment
Tuesday, October 7, 2008 - 16:42
in Health & Medicine
Older and younger patients with renal cancer derive similar benefit from sorafenib therapy and tolerate the drug equally well, according to a study published online October 7 in the Journal of the National Cancer Institute.